Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization

Figure 1 PSE treatment for a 68-year-old male case of HCC with splenomegaly and thrombocytopenia. A: Splenic arteriography before PSE showing the whole splenic parnchymal image; B: Splenic arteriography after PSE showing the residual splenic parnchymal image, part of the peripheral splenic parenchyma was ablated, and the extent of embolization was roughly estimated of approximately 60%; C: Celiac arteriography before TACE showing the tumor blood-supply image; D: TACE is terminated when the tumor is filled with emulsifier; E: Transverse CT image revealing splenomegaly at 1 wk before PSE/TACE; F: Transverse CT image revealing the infarction of peripheral splenic parenchyma at 2 wk after PSE. The extent of embolization was 62% calculated by CT volume analysis software.